Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-10-029698
Filing Date
2010-05-27
Accepted
2010-05-27 12:34:25
Documents
2
Period of Report
2010-05-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 rrd276964.html 3  
1 FORM 3 rrd276964.xml 3 2196
2 POA rrd248148_280014.htm EX-24. 3350
  Complete submission text file 0001181431-10-029698.txt   7412
Mailing Address 7808 HARDWICK DR RALEIGH NC 27615
Business Address
RUSCHER ROBERT L (Reporting) CIK: 0001106813 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34641 | Film No.: 10861605

Mailing Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560
Business Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560 919-380-2000
Furiex Pharmaceuticals, Inc. (Issuer) CIK: 0001484478 (see all company filings)

EIN.: 271197863 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations